Highest-materiality recent filing
Marchex closes acquisition of Archenia for $10M in convertible notes plus earnout shares
Acquired 100% of Archenia, a performance-based marketing tech company, for $10M in 6% convertible notes due in 3 tranches over 24 months.
Revenue $10.6M (-7% YoY); net loss $1.7M ($0.04/sh) vs $2.0M ($0.05/sh); Adj EBITDA loss $0.1M.
Marchex to acquire Archenia for $10M in convertible notes plus earn-out shares
Base consideration: $10M in convertible promissory notes at 6% interest, payable in three equal tranches at 12, 18, and 24 months post-close.
Marchex subleases Seattle office space, records ~$203K impairment
Entered sublease with RentSpree for 12,300 sq ft at 1200 5th Ave, Seattle.
Marchex settles civil lawsuit for $2M, payments spread over 13 months
Settlement agreement signed April 14, 2026 resolves all claims in Barnard and McEvenue v. Marchex.
GAAP revenue $10.8M in Q4 vs $11.9M YoY; net loss per share $(0.05) vs $(0.04).
Marchex grants 280,447 RSUs to three officers; vest fully in one year
Troy Hartless (President & CRO) awarded 128,205 RSUs vesting on first anniversary of Feb 17, 2026.
Marchex approves FY2025 cash bonuses: Hartless $200K, Feeney $150K, Nagle $40K
Troy Hartless, President & CRO, receives $200,000 annual cash bonus for FY2025.
Marchex grants 50,000 options to each director; annual meeting re-elects all nominees
Each director granted 50,000 stock options under 2021 Plan, vesting 50% annually over two years; exercise price at Dec 16 close.
Marchex Q3 revenue falls to $11.5M, net loss $1M; agrees to acquire Archenia for $10M note
Q3 revenue $11.5M vs $12.6M YoY (-8.7%); net loss $1.0M ($0.02 loss per share).
Marchex approves executive salary increases and equity grants to three officers
Base salary raised to $400k for President/CRO Hartless, $375k for COO/CLO Feeney, $275k for CFO Nagle.
Marchex CEO Edwin Miller resigns; Hartless appointed President, Feeney COO, Nagle CFO
CEO Edwin Miller resigns effective Sep 11, 2025; will serve as senior advisor to Chairman for one year at $150k annual comp and eligible for 2025 bonus.
Marchex Q2 revenue down 3% YoY to $11.7M; net income $0.1M; guides Q3 EBITDA up >50% sequentially
GAAP revenue $11.7M vs $12.1M Q2 2024; net income $0.1M ($0.00 EPS) vs net loss $0.8M.
Marchex Q1 revenue $11.4M (-2% YoY), net loss $2.0M; sees Q2 sequential growth, positive EBITDA
GAAP revenue $11.4M vs $11.6M YoY; net loss $2.0M ($0.05/share) vs $1.5M loss.
Marchex grants 201,250 RSUs to CEO, CRO, and PFO
CEO Edwin Miller granted 106,250 RSUs; CRO Troy Hartless 87,500; PFO Brian Nagle 7,500.
Marchex Q4 revenue down 4% YoY to $11.9M; net loss widens; appoints new CFO Brian Nagle
Q4 revenue $11.9M (down from $12.4M); net loss $1.9M ($0.04 loss per diluted share) vs $1.1M loss last year.
Marchex CFO Holly Aglio terminated; Brian Nagle named principal financial officer
Holly Aglio's employment as CFO terminated effective January 10, 2025.
Marchex enters consulting agreement with Vice Chairman Arends; grants 75,000 options
$180,000 upfront payment to Michael Arends for strategic consulting in FY2025.
Marchex grants 50,000 stock options to each director and $7,500 quarterly cash retainer
Each director receives 50,000 stock options under 2021 Stock Incentive Plan.
Marchex Q3 revenue $12.6M (-2% YoY); net loss narrows to $0.8M from $1.5M
GAAP revenue $12.6M vs $12.8M Q3 2023; net loss $0.8M ($0.02/diluted share) vs $1.5M ($0.04).
Marchex Q2 2024 revenue $12.1M, net loss improves to $0.8M; adjusted EBITDA positive $0.3M
GAAP revenue $12.1M vs $12.5M YoY; net loss $(0.8M) or $(0.02)/diluted share vs $(2.7M) or $(0.06) in Q2 2023.
Marchex grants 400k stock options to CEO Miller and 300k to CRO Hartless; updates severance terms
CEO Miller: 250k options (4-yr, 25% yr1) plus 150k options (cliff vest yr4); exercise price = July 26 close.
Marchex Q1 revenue falls 5% to $11.6M, net loss narrows to $1.5M
GAAP revenue $11.6M, down from $12.2M YoY; net loss $1.5M ($0.03/shr) vs $4.5M ($0.11/shr) in prior year.
Marchex Q1 revenue $11.6M (-5% YoY); net loss narrows to $1.5M
GAAP revenue $11.6M vs $12.2M Q1 2023; net loss improved to $1.5M ($0.03 per share) from $4.5M.
Marchex Q4 2023 revenue $12.4M; net loss narrows to $1.1M; adjusted EBITDA turns positive
Q4 GAAP revenue $12.4M (flat YoY); net loss $1.1M vs $3.6M loss in Q4 2022.
Marchex CEO Edwin Miller adopts 10b5-1 plan to purchase up to $50,000 of MCHX shares
CEO Edwin Miller adopted a stock purchase plan on Nov 15, 2023 to buy up to $50,000 of Marchex Class B common stock.
Marchex Q3 revenue $12.8M, down 3% YoY; adjusted EBITDA turns positive to $370K
GAAP revenue $12.8M vs $13.2M YoY; net loss $1.5M ($0.04/diluted share) vs $1.6M ($0.04).
Marchex appoints Holly Aglio as CFO effective October 30, 2023
Holly Aglio appointed CFO, previously CFO of NetCentrics (2021-2023) and financial roles at Govplace, Artel, Apptis, and PwC.
Marchex re-elects all directors; grants options to CEO and CRO at $1.45 strike
All five director nominees re-elected at annual meeting on Sept 28, 2023, with 139M+ votes for each.
Marchex President and COO Ryan Polley resigns effective Sep 30, 2023
Ryan Polley resigned as President and COO on Aug 31, 2023 to pursue other opportunities.
Marchex Q2 revenue falls 7.4% YoY to $12.5M; net loss widens to $2.7M
GAAP revenue $12.5M vs $13.5M in Q2 2022; net loss $2.7M ($0.06/diluted share) vs $1.5M loss.
Marchex Q1 revenue $12.2M (-7.6% YoY); net loss widens to $4.5M
GAAP revenue $12.2M vs $13.2M in Q1 2022; net loss $4.5M ($0.11/share) vs $1.6M loss ($0.04) prior year.
Hartless joined as CRO effective April 3, 2023; annual base salary $375,000.
Marchex recovers all $10.1M from SVB accounts after bank failure
Total exposure: ~$4.6M in SVB bank account + ~$5.5M in money market account (third-party custodian).
Marchex discloses $4.6M at Silicon Valley Bank; says no material impact after FDIC action
Marchex had ~$4.6M in a bank account at SVB and ~$5.5M in a money market account managed by SVB Asset Management (securities held at non-SVB custodian).
Marchex Q4 revenue $12.3M, net loss $0.08/share; full-year revenue $52.2M, net loss $0.19/share
GAAP revenue $12.3M in Q4 2022, down from $12.8M in Q4 2021; full-year revenue $52.2M vs $53.5M.
Marchex appoints Edwin Miller as CEO; Polley becomes President; Horowitz and Arends in new roles
Edwin Miller named CEO effective Feb 3, 2023; base salary $425,000, bonus target $376,250, and 675,000 stock options.
Marchex grants stock options and restricted stock to three executive officers
Russell Horowitz: 51,000 options + 51,000 restricted shares.
Marchex approves 2023 bonus pool of $568K and equity grants to executives
Aggregate bonus pool target amount $568,438; maximum payout 195% of target.
Marchex enters sublease for Seattle office space; total rent ~$1.77M through Sep 2027
Sublease covers 12,300 sq ft at 1200 5th Avenue, Suite 1300, Seattle.
Marchex dismisses Moss Adams as auditor, engages RSM US LLP
Dismissed Moss Adams as independent auditor on Nov 11, 2022; engaged RSM US LLP same day.
Marchex Q3 revenue $13.2M (-3.6% YoY), net loss $1.6M vs income $3.3M YoY
GAAP revenue of $13.2M, down from $13.7M in Q3 2021; net loss of $1.6M ($0.04 loss per share) vs net income of $3.3M ($0.07 EPS) a year ago.
Marchex grants equity to directors; stockholders re-elect all nominees at 2022 annual meeting
Each director receives 15,000 restricted shares ($0.01/share) and 20,000 options at $1.78 exercise price.
Marchex terminates Seattle office lease; will make $671k payment by March 31, 2023.
Exercised lease termination option for Seattle office at 520 Pike Street, Suite 2000, effective March 31, 2023.
Marchex Q2 2022 revenue down 3.6% YoY to $13.5M; net loss widens to $1.5M
GAAP revenue $13.5M vs $14.0M in Q2 2021; net loss $1.5M ($0.03 per share) vs $0.3M loss prior year.
Marchex Q1 revenue $13.2M, net loss narrows to $1.6M; adjusted EBITDA turns positive $151k
GAAP revenue $13.2M (Q1 2022) vs $13.0M (Q1 2021); core analytics revenue $13.2M.
Marchex Co-CEO Michael Arends adopts 10b5-1 stock purchase plan for 2022
Co-CEO Michael Arends adopted a Rule 10b5-1 plan to buy Marchex Class B common stock in 2022.
Marchex Q4 2021 revenue $12.8M, net loss narrows to $2.0M; adjusted EBITDA near break-even
GAAP revenue Q4 2021 $12.8M (up from $12.7M Q4 2020); full-year $53.5M (up from $51.2M).
Marchex grants 210K stock options and 210K RSUs to four executive officers
Russell Horowitz: 51,000 options and 51,000 RSUs granted on Jan 3, 2022.
Marchex CFO Leila Kirske resigns; Co-CEO Arends assumes principal financial officer role
Leila Kirske resigned as CFO effective December 31, 2021 to pursue other opportunities.
On March 6, 2025, Marchex announces that Brian Nagle (“Nagle”), SVP, Corporate Controller of Marchex, had been appointed Principal Financial Officer and Principal Accounting Officer of the Company.
Brian Nagle, the Company’s Senior Vice President/Corporate Controller, will be appointed as the Company’s Principal Financial Officer and Principal Accounting Officer.
On January 10, 2025, Marchex, Inc. (the “Company”) announced the termination of employment of Holly Aglio (“Aglio”), Chief Financial Officer of the Company, effective as of that date.
On October 31, 2023, Marchex, Inc. (“Marchex” or the “Company”) announced that Holly A. Aglio (“Aglio”) joined Marchex as its Chief Financial Officer effective October 30, 2023
On August 31, 2023, Ryan Polley resigned as the Company’s President and Chief Operating Officer to pursue other career opportunities.
On April 4, 2023, Marchex, Inc. (“Marchex” or the “Company”) announced that Troy Hartless (“Hartless”) joined Marchex as its Chief Revenue Officer effective April 3, 2023 (the “Start Date”).
On February 6, 2023, Marchex, Inc. (“Marchex” or the “Company”) announced that Edwin A. Miller (“Miller”) joined Marchex as its Chief Executive Officer effective February 3, 2023 (the “Start Date”).
Michael Arends, the Company’s Co-CEO, who previously served as the Company’s Chief Financial Officer from May 2003 through April 2021, will serve as the Company’s Principal Financial Officer and Principal Accounting Officer and oversee the senior members of the Company’s finance department until a successor Chief Financial Officer is named.
Effective on December 31, 2021, Leila Kirske resigned as Chief Financial Officer of Marchex, Inc. (the “Company”) to pursue other opportunities.
On August 13, 2021, the Board of Directors of Marchex, Inc. (“Marchex” or the “Company”) appointed Ryan Polley (“Polley”) to the position of Chief Operating Officer of Marchex.
Max materiality 0.75 · Median 0.55 · Most common event earnings